ClinicalTrials.gg
Drug

Bacitracin clinical trials

studies test it
10
open now
1
in phase 3
1
first study started
2005

How each study uses Bacitracin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Bacitracin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
8 Sept 1948 · BACIGUENT · ANDA 060734 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bacitracin
5

Brand

Baciguent
1

Studies by the year they started

10 studies that test it; most in 2009 (2)

Studies that test Bacitracin, by start year
YearStudies
20051
20061
20092
20101
20111
20122
20171
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
2
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 8

Washington University School of Medicine (1) · University of Louisville (1) · Healthpoint (1) · Steward St. Elizabeth's Medical Center of Boston, Inc. (1) · Population Health Research Institute (1) · Mekos Laboratories AS (1) · National Taiwan University Hospital (1) · Susan Hassenbein (1)

Often tested with

Tested in the same studies.

Cefazolin (2) · Gentamicins (1) · Topical Wound Spray HP802-247 (1) · Cephalexin (1) · Polymyxin B (1) · Neomycin (1) · Ascorbic Acid (1) · Bismuth tribromophenate (1)

Studies

Open first, then newest update. How each study uses Bacitracin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 10

As the comparator · 2 — what is tested is compared with Bacitracin

Codes

What other systems call Bacitracin · ClinicalTrials.gg INT007042

  • MeSH (NLM) D001414BacitracinOne source ClinicalTrials.gov
  • UNII (FDA) 58H6RWO52IBACITRACINOne source FDA
  • RxNorm 1291One source FDA
  • NCI Thesaurus C295BacitracinOne source FDA

Also registered as bacitracin zinc (UNII 89Y4M234ES · RxNorm 11417).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.